273 related articles for article (PubMed ID: 21697136)
1. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication.
Wong TT; Zhou L; Li J; Tong L; Zhao SZ; Li XR; Yu SJ; Koh SK; Beuerman RW
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7385-91. PubMed ID: 21697136
[TBL] [Abstract][Full Text] [Related]
2. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.
Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D
J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875
[TBL] [Abstract][Full Text] [Related]
3. Elevation of human alpha-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium.
Zhou L; Beuerman RW; Ang LP; Chan CM; Li SF; Chew FT; Tan DT
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2077-86. PubMed ID: 19168894
[TBL] [Abstract][Full Text] [Related]
4. Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea.
Lopilly Park HY; Kim JH; Lee KM; Park CK
Exp Eye Res; 2012 Jan; 94(1):13-21. PubMed ID: 22067128
[TBL] [Abstract][Full Text] [Related]
5. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
6. Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry.
Li B; Sheng M; Xie L; Liu F; Yan G; Wang W; Lin A; Zhao F; Chen Y
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):177-86. PubMed ID: 24282230
[TBL] [Abstract][Full Text] [Related]
7. Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma.
Pieragostino D; Bucci S; Agnifili L; Fasanella V; D'Aguanno S; Mastropasqua A; Ciancaglini M; Mastropasqua L; Di Ilio C; Sacchetta P; Urbani A; Del Boccio P
Mol Biosyst; 2012 Apr; 8(4):1017-28. PubMed ID: 22124706
[TBL] [Abstract][Full Text] [Related]
8. Analysis of inflammatory cytokines in the tears of dry eye patients.
Massingale ML; Li X; Vallabhajosyula M; Chen D; Wei Y; Asbell PA
Cornea; 2009 Oct; 28(9):1023-7. PubMed ID: 19724208
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
10. Tear film osmolarity in patients treated for glaucoma or ocular hypertension.
Labbé A; Terry O; Brasnu E; Van Went C; Baudouin C
Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490
[TBL] [Abstract][Full Text] [Related]
11. Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients.
Altiparmak UE; Acar DE; Ozer PA; Emec SD; Kasim R; Ustun H; Duman S
Eye (Lond); 2010 Jun; 24(6):1044-50. PubMed ID: 19834507
[TBL] [Abstract][Full Text] [Related]
12. Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye.
Wong ABC; Wang MTM; Liu K; Prime ZJ; Danesh-Meyer HV; Craig JP
Ocul Surf; 2018 Jul; 16(3):289-293. PubMed ID: 29510226
[TBL] [Abstract][Full Text] [Related]
13. Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen's disease: a tear proteomic study.
Mukhopadhyay S; Sen S; Datta H
Br J Ophthalmol; 2015 Jan; 99(1):108-12. PubMed ID: 25138758
[TBL] [Abstract][Full Text] [Related]
14. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests.
VanDerMeid KR; Su SP; Ward KW; Zhang JZ
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1512-8. PubMed ID: 22323462
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of acupuncture and identification of tear protein expression changes using iTRAQ quantitative proteomics in rabbits.
Qiu X; Gong L; Sun X; Guo J; Chodara AM
Curr Eye Res; 2011 Oct; 36(10):886-94. PubMed ID: 21950693
[TBL] [Abstract][Full Text] [Related]
16. [Ocular surface in glaucoma patients with topical treatment].
Zemba M; Papadatu CA; Enache VE; Sârbu LN
Oftalmologia; 2011; 55(3):94-8. PubMed ID: 22428298
[TBL] [Abstract][Full Text] [Related]
17. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival cytokine expression in symptomatic moderate dry eye subjects.
Narayanan S; Miller WL; McDermott AM
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2445-50. PubMed ID: 16723455
[TBL] [Abstract][Full Text] [Related]
19. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
20. Tear cytokine profile in medicated glaucoma patients: effect of monocyte chemoattractant protein 1 on early posttrabeculectomy outcome.
Chong RS; Jiang YZ; Boey PY; Yu SJ; Htoon HM; Aung T; Khaw PT; Wong TT
Ophthalmology; 2010 Dec; 117(12):2353-8. PubMed ID: 20630596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
